# US 2024/0043382 A1 · Modified indole alkaloids for therapeutic uses

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0043382 A1
- Document ID: US20240043382A1
- Status: Published application
- Kind: A1
- Application number: 18/267,827
- Filed: 2021-12-17
- Published: 2024-02-08
- Earliest claimed: 2020-12-18
- Assignees: Compass Pathfinder Limited
- Applicants: Compass Pathfinder Limited
- Inventors: Ryan PROTZKO
- Web page: https://patentgrep.com/patent/US20240043382A1

## CPC

- A61P 25/06: Antimigraine agents
- C07D 209/16: Tryptamines
- A61P 25/22: Anxiolytics
- A61P 25/24: Antidepressants
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A61P 25/30: for treating abuse or dependence
- C07D 471/14: Ortho-condensed systems
- C07D 471/18: Bridged systems
- C07D 487/22: in which the condensed system contains four or more hetero rings
- C07F 9/5728: {condensed with carbocyclic rings or carbocyclic ring systems}
- C07H 17/02: Heterocyclic radicals containing only nitrogen as ring hetero atoms
- C07H 17/08: Hetero rings containing eight or more ring members, e.g. erythromycins
- C12N 9/1007: {Methyltransferases (general) (2.1.1.)}
- C12N 9/1033: {Chloramphenicol O-acetyltransferase (2.3.1.28)}
- C12N 9/1051: {Hexosyltransferases (2.4.1)}
- C12N 9/1205: {Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases}
- C12N 9/13: {transferring sulfur containing groups (2.8)}
- C12N 9/88: Lyases (4.)
- C12P 9/00: Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen {(phosphoglycerides, C12P7/6481)}
- C12P 11/00: Preparation of sulfur-containing organic compounds
- C12P 17/10: Nitrogen as only ring hetero atom
- C12P 17/182: {Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system (alloxazine or isoalloxazine, e.g. riboflavine C12P25/00)}
- C12P 19/60: having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin {(C12P19/605)}
- C12Y 201/01004: Acetylserotonin O-methyltransferase (2.1.1.4)
- C12Y 201/01049: Amine N-methyltransferase (2.1.1.49)
- C12Y 203/01084: Alcohol O-acetyltransferase (2.3.1.84)
- C12Y 204/01017: Glucuronosyltransferase (2.4.1.17)
- C12Y 402/0102: Tryptophan synthase (4.2.1.20)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Y: ENZYMES

## Abstract

Disclosed herein are enzymatic and modified host cell methods for prepared modified indole alkaloids. Also disclosed herein are modified indole alkaloids and their therapeutic use for treating diseases and disorders.

## Claims

### Claim 1

A compound of Formula (Ia):
or a pharmaceutically acceptable salt thereof, wherein,
R1 and R10 are independently selected from hydrogen, C1-C6 alkyl, C2-C6 alkenyl, and C2-C6 alkynyl, wherein alkyl, alkenyl, and alkynyl are optionally substituted with one or more substituents independently selected from halo, —OMe, —CN, —NH2, and —NO2;
R8 is —CR′2—, wherein each R′ is independently selected from hydrogen, halo, haloalkyl, alkoxy, haloalkoxy, and amine;
n is selected from 2, 3, and 4;
R9 is selected from C2-C6 alkyl, C2-C6 alkenyl, and C2-C6 alkynyl, wherein alkyl, alkenyl, and alkynyl are optionally substituted with one or more substituents independently selected from halo, —OMe, —CN, —NH2, —NO2, and 3- to 8-membered heterocycle, and wherein 3- to 8-membered heterocycle is optionally substituted with one or more substituents independently selected from halo, —OMe, —CN, —NH2, and —NO2;
R2 is selected from hydrogen, halogen, C1-C6 alkyl, and C1-C6 haloalkyl;
R4, R5, R6, and R7 are each independently selected from hydrogen, C1-C6 alkyl, A, J, Q, and X;
A is
J is
Q is
X is selected from glucose, xylose, galactose, rhamnose, rutinose, and disaccharide;
R13 is selected from hydrogen, and C1-C6 alkyl optionally substituted with one or more substituents independently selected from C1-C6 alkyl, oxo, halo, —OMe, —CN, —NH2, and —NO2;
R14 is selected from C1-C6 alkyl and C2-C6 alkenyl, wherein C1-C6 alkyl and C2-C6 alkenyl are optionally substituted with one or more substituents independently selected from halo, —OMe, —CN, —NH2, and —NO2;
or R13 and R14 taken together with the atom to which they are attached to form a substituted or unsubstituted C3-C8cycloalkyl or substituted or unsubstituted 3- to 8-membered heterocycloalkyl having 1 or 2 heteroatoms each independently selected from N, O, and S;
R15 is selected from C1-C6 alkylene and C2-C6 alkenylene, wherein C1-C6 alkylene and C2-C6 alkenylene are optionally substituted with one or more substituents independently selected from C1-C6 alkyl, halo, —OMe, —CN, —NH2, and —NO2; and
wherein at least one of R4, R5, R6, and R7 is A, J, Q, or X.

### Claim 2 (depends on 1)

The compound or salt of claim 1, wherein R1 is selected from hydrogen and C1-C3 alkyl.

### Claim 3 (depends on 1, 2)

The compound or salt of claim 1 or 2, wherein R1 is hydrogen.

### Claim 4 (depends on 1, 2, 3)

The compound or salt of any of claims 1 to 3, wherein R10 is independently selected from hydrogen, C1-C3 alkyl, and C2-C3 alkenyl, wherein alkyl and alkenyl are optionally substituted with one or more substituents independently selected from halo, —OMe, and —CN.

### Claim 5 (depends on 1, 2, 3, 4)

The compound or salt of any of claims 1 to 4, wherein each R′ is independently selected from hydrogen, halo, and haloalkyl.

### Claim 6 (depends on 1, 2, 3, 4, 5)

The compound or salt of any of claims 1 to 5, wherein each R′ is hydrogen.

### Claim 7 (depends on 1, 2, 3, 4, 5, 6)

The compound or salt of any of claims 1 to 6, wherein n is selected from 2 and 3.

### Claim 8 (depends on 1, 2, 3, 4, 5, 6, 7)

The compound or salt of any of claims 1 to 7, wherein n is 2.

### Claim 9 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

The compound or salt of any of claims 1 to 8, wherein R9 is selected from C2-C3 alkyl and C2-C3 alkenyl, wherein alkyl and alkenyl are optionally substituted with one or more substituents independently selected from halo, —OMe, and —CN.

### Claim 10 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9)

The compound or salt of any of claims 1 to 9, wherein R9 is C2-C3 alkyl.

### Claim 11 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

The compound or salt of any of claims 1 to 10, wherein R2 is selected from hydrogen, halogen, and C1-C6 alkyl.

### Claim 12 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11)

The compound or salt of any of claims 1 to 11, wherein R2 is hydrogen.

### Claim 13 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)

The compound or salt of any of claims 1 to 12, wherein R4, R5, R6, and R7 are each independently selected from hydrogen, A, J, Q, and X.

### Claim 14 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)

The compound or salt of any of claims 1 to 13, wherein R4, R5, R6, and R7 are each independently selected from hydrogen, J, and Q.

### Claim 15 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)

The compound or salt of any of claims 1 to 14, wherein at least one of R4, R5, R6, and R7 is A or Q.

### Claim 16 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)

The compound or salt of any of claims 1 to 14, wherein at least one of R5, R6, and R7 is J or X.

### Claim 17 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)

The compound or salt of any of claims 1 to 16, wherein R13 is selected from hydrogen and C1-C3 alkyl optionally substituted with one or more substituents independently selected from C1-C6 alkyl, oxo, halo, —OMe, and —CN.

### Claim 18 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)

The compound or salt of any of claims 1 to 17, wherein R13 is hydrogen.

### Claim 19 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)

The compound or salt of any of claims 1 to 17, wherein R13 is C1-C3 alkyl.

### Claim 20 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19)

The compound or salt of any of claims 1 to 19, wherein R14 is C1-C3 alkyl optionally substituted with one or more substituents independently selected from halo, —OMe, and —CN.

### Claim 21 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20)

The compound or salt of any of claims 1 to 20, wherein R15 is C1-C3 alkylene optionally substituted with one or more substituents independently selected from C1-C6 alkyl, oxo, halo, —OMe, and —CN.

### Claim 22 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21)

The compound or salt of any of claims 1 to 21, wherein X is selected from glucose, galactose, and rhamnose.

### Claim 23

A method of treating a disease or disorder in a subject in need thereof comprising administering a compound of Formula (Ia):
or a pharmaceutically acceptable salt thereof, wherein,
R1 and R10 are independently selected from hydrogen, C1-C6 alkyl, C2-C6 alkenyl, and C2-C6 alkynyl, wherein alkyl, alkenyl, and alkynyl are optionally substituted with one or more substituents independently selected from halo, —OMe, —CN, —NH2, and —NO2;
R8 is —CR′2—, wherein each R′ is independently selected from hydrogen, halo, haloalkyl, alkoxy, haloalkoxy, and amine;
n is selected from 2, 3, and 4;
R9 is selected from C2-C6 alkyl, C2-C6 alkenyl, and C2-C6 alkynyl, wherein alkyl, alkenyl, and alkynyl are optionally substituted with one or more substituents independently selected from halo, —OMe, —CN, —NH2, —NO2, and 3- to 8-membered heterocycle, and wherein 3- to 8-membered heterocycle is optionally substituted with one or more substituents independently selected from halo, —OMe, —CN, —NH2, and —NO2;
R2 is selected from hydrogen, halogen, C1-C6 alkyl, and C1-C6 haloalkyl;
R4, R5, R6, and R7 are each independently selected from hydrogen, C1-C6 alkyl, A, J, Q, and X;
A is
J is
Q is
X is selected from glucose, xylose, galactose, rhamnose, rutinose, and disaccharide;
R13 is selected from hydrogen, and C1-C6 alkyl optionally substituted with one or more substituents independently selected from C1-C6 alkyl, oxo, halo, —OMe, —CN, —NH2, and —NO2;
R14 is selected from C1-C6 alkyl and C2-C6 alkenyl, wherein C1-C6 alkyl and C2-C6 alkenyl are optionally substituted with one or more substituents independently selected from halo, —OMe, —CN, —NH2, and —NO2;
or R13 and R14 taken together with the atom to which they are attached to form a substituted or unsubstituted C3-C8cycloalkyl or substituted or unsubstituted 3- to 8-membered heterocycloalkyl having 1 or 2 heteroatoms each independently selected from N, O, and S;
R15 is selected from C1-C6 alkylene and C2-C6 alkenylene, wherein C1-C6 alkylene and C2-C6 alkenylene are optionally substituted with one or more substituents independently selected from C1-C6 alkyl, halo, —OMe, —CN, —NH2, and —NO2; and
wherein at least one of R4, R5, R6, and R7 is A, J, Q, or X.

### Claim 24 (depends on 23)

The method of claim 23, wherein R1 is selected from hydrogen and C1-C3 alkyl.

### Claim 25 (depends on 23, 24)

The method of claim 23 or 24, wherein R1 is hydrogen.

### Claim 26 (depends on 23, 24, 25)

The method of any of claims 23 to 25, wherein R10 is independently selected from hydrogen, C1-C3 alkyl, and C2-C3 alkenyl, wherein alkyl and alkenyl are optionally substituted with one or more substituents independently selected from halo, —OMe, and —CN.

### Claim 27 (depends on 23, 24, 25, 26)

The method of any of claims 23 to 26, wherein each R′ is independently selected from hydrogen, halo, and haloalkyl.

### Claim 28 (depends on 23, 24, 25, 26, 27)

The method of any of claims 23 to 27, wherein each R′ is hydrogen.

### Claim 29 (depends on 23, 24, 25, 26, 27, 28)

The method of any of claims 23 to 28, wherein n is selected from 2 and 3.

### Claim 30 (depends on 23, 24, 25, 26, 27, 28, 29)

The method of any of claims 23 to 29, wherein n is 2.

### Claim 31 (depends on 23, 24, 25, 26, 27, 28, 29, 30)

The method of any of claims 23 to 30, wherein R9 is selected from C2-C3 alkyl and C2-C3 alkenyl, wherein alkyl and alkenyl are optionally substituted with one or more substituents independently selected from halo, —OMe, and —CN.

### Claim 32 (depends on 23, 24, 25, 26, 27, 28, 29, 30, 31)

The method of any of claims 23 to 31, wherein R9 is C2-C3 alkyl.

### Claim 33 (depends on 23, 24, 25, 26, 27, 28, 29, 30, 31, 32)

The method of any of claims 23 to 32, wherein R2 is selected from hydrogen, halogen, and C1-C6 alkyl.

### Claim 34 (depends on 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33)

The method of any of claims 23 to 33, wherein R2 is hydrogen.

### Claim 35 (depends on 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34)

The method of any of claims 23 to 34, wherein R4, R5, R6, and R7 are independently selected from hydrogen, A, J, Q, and X.

### Claim 36 (depends on 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35)

The method of any of claims 23 to 35, wherein R4, R5, R6, and R7 are independently selected from hydrogen, J, and Q.

### Claim 37 (depends on 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36)

The method of any of claims 23 to 36, wherein at least one of R4, R5, R6, and R7 is A or Q.

### Claim 38 (depends on 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36)

The method of any of claims 23 to 36, wherein at least one of R5, R6, and R7 is J or X.

### Claim 39 (depends on 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38)

The method of any of claims 23 to 38, wherein R13 is selected from hydrogen and C1-C3 alkyl optionally substituted with one or more substituents independently selected from C1-C6 alkyl, oxo, halo, —OMe, and —CN.

### Claim 40 (depends on 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39)

The method of any of claims 23 to 39, wherein R13 is hydrogen.

### Claim 41 (depends on 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39)

The method of any of claims 23 to 39, wherein R13 is C1-C3 alkyl.

### Claim 42 (depends on 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41)

The method of any of claims 23 to 41, wherein R14 is C1-C3 alkyl optionally substituted with one or more substituents independently selected from halo, —OMe, and —CN.

### Claim 43 (depends on 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42)

The method of any of claims 23 to 42, wherein R15 is C1-C3 alkylene optionally substituted with one or more substituents independently selected from C1-C6 alkyl, oxo, halo, —OMe, and —CN.

### Claim 44 (depends on 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43)

The method of any of claims 23 to 43, wherein X is selected from glucose, galactose, and rhamnose.

### Claim 45 (depends on 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44)

The method of any of claims 23 to 44, wherein the disease or disorder is major depression, treatment resistant depression, addiction, anxiety, post-traumatic stress disorder, prolonged grief disorder, complicated grief disorder, mania, psychosis, insomnia, hypersomnia, pain, Alzheimers disease, Parkinson's disease, burnout, cluster headaches, binge eating, migraine headaches, or irritable bowel syndrome.

### Claim 46 (depends on 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45)

The method of any of claims 23 to 45, wherein the disease or disorder is major depression, treatment resistant depression, addiction, anxiety, post-traumatic stress disorder, prolonged grief disorder, complicated grief disorder, or binge eating.

### Claim 47

A method of treating a disease or disorder in a subject in need thereof comprising administering a modified indole alkaloid.

### Claim 48 (depends on 47)

The method of claim 47, wherein the modified indole alkaloid is a modified tryptamine alkaloid, a modified ibogamine alkaloid, a modified ergoline alkaloid, a modified beta-carboline alkaloid, or a modified mitragynine alkaloid.

### Claim 49 (depends on 47, 48)

The method of claim 47 or 48, wherein the modified indole alkaloid is an acetylated indole alkaloid, an acylated indole alkaloid, a methylated indole alkaloid, a phosphorylated indole alkaloid, a sulfonylated indole alkaloid, or a glycosylated indole alkaloid.

### Claim 50

A method of enzymatically preparing an indole alkaloid, comprising:
contacting a compound of Formula (Ia′) with an enzyme and a co-substrate;
wherein the compound of Formula (Ia′) has a structure of:
or a pharmaceutically acceptable salt thereof, wherein,
R1 and R10 are independently selected from hydrogen, C1-C6 alkyl, C2-C6 alkenyl, and C2-C6 alkynyl, wherein alkyl, alkenyl, and alkynyl are optionally substituted with one or more substituents independently selected from halo, —OMe, —CN, —NH2, and —NO2;
R8 is —CR′2—, wherein each R′ is independently selected from hydrogen, halo, haloalkyl, alkoxy, haloalkoxy, and amine;
n is selected from 2, 3, and 4;
R9 is selected from C2-C6 alkyl, C2-C6 alkenyl, and C2-C6 alkynyl, wherein alkyl, alkenyl, and alkynyl are optionally substituted with one or more substituents independently selected from halo, —OMe, —CN, —NH2, —NO2, and 3- to 8-membered heterocycle, and wherein 3- to 8-membered heterocycle is optionally substituted with one or more substituents independently selected from halo, —OMe, —CN, —NH2, and —NO2;
R2 is selected from hydrogen, halogen, C1-C6 alkyl, and C1-C6 haloalkyl;
R4, R5, R6, and R7 are each independently selected from hydrogen, —OH, and C1-C6 alkyl; and
wherein at least one of R4, R5, R6, and R7 is —OH.

### Claim 51 (depends on 50)

The method of claim 50, wherein R4 is —OH.

### Claim 52 (depends on 50)

The method of claim 50, wherein R5 is —OH.

### Claim 53 (depends on 50)

The method of claim 50, wherein R6 is —OH.

### Claim 54 (depends on 50)

The method of claim 50, wherein R7 is —OH.

### Claim 55 (depends on 50, 51, 52, 53, 54)

The method of any one of claims 50-54, wherein the enzyme is a 4-hydroxytryptamine kinase.

### Claim 56 (depends on 50, 51, 52, 53, 54)

The method of any one of claims 50-54, wherein the enzyme is an acetylserotonin O-methyltransferase.

### Claim 57 (depends on 50, 51, 52, 53, 54)

The method of any one of claims 50-54, wherein the enzyme is a tryptamine n-methyltransferase.

### Claim 58 (depends on 50, 51, 52, 53, 54)

The method of any one of claims 50-54, wherein the enzyme is a sulfotransferase 1A1.

### Claim 59 (depends on 50, 51, 52, 53, 54)

The method of any one of claims 50-54, wherein the enzyme is a sulfotransferase 1A3.

### Claim 60 (depends on 50, 51, 52, 53, 54)

The method of any one of claims 50-54, wherein the enzyme is an alcohol O-acetyltransferase 1.

### Claim 61 (depends on 50, 51, 52, 53, 54)

The method of any one of claims 50-54, wherein the enzyme is a chloramphenicol acetyltransferase.

### Claim 62 (depends on 50, 51, 52, 53, 54)

The method of any one of claims 50-54, wherein the enzyme is an UDP-glucuronosyltransferase.

### Claim 63 (depends on 50, 51, 52, 53, 54)

The method of any one of claims 50-54, wherein the enzyme is an oleandomycin glycosyltransferase.

### Claim 64 (depends on 50, 51, 52, 53, 54)

The method of any one of claims 50-54, wherein the enzyme is a glycosyltransferase.

### Claim 65 (depends on 50, 51, 52, 53, 54)

The method of any one of claims 50-54, wherein the enzyme is a 4-dimethylallyl tryptophan synthase.

### Claim 66 (depends on 50, 51, 52, 53, 54)

The method of any one of claims 50-54, wherein the enzyme is a 7-dimethylallyltryptophan synthase.
